| Q36534069 | A Group of Novel Serum Diagnostic Biomarkers for Multidrug-Resistant Tuberculosis by iTRAQ-2D LC-MS/MS and Solexa Sequencing |
| Q33564551 | A genomic portrait of the genetic architecture and regulatory impact of microRNA expression in response to infection |
| Q36903313 | Actin-binding protein regulation by microRNAs as a novel microbial strategy to modulate phagocytosis by host cells: the case of N-Wasp and miR-142-3p |
| Q37617402 | Activation of the Wnt Pathway by Mycobacterium tuberculosis: A Wnt-Wnt Situation |
| Q36296580 | Alternate splicing of transcripts shape macrophage response to Mycobacterium tuberculosis infection |
| Q52783726 | Anti-inflammatory effects of curcumin are associated with down regulating microRNA-155 in LPS-treated macrophages and mice. |
| Q61812135 | Antithetical Effects of MicroRNA Molecules in Tuberculosis Pathogenesis |
| Q40602555 | Association between tuberculosis and circulating microRNA hsa-let-7b and hsa-miR-30b: A pilot study in a Chinese population |
| Q36889667 | Autophagy-Related Proteins Target Ubiquitin-Free Mycobacterial Compartment to Promote Killing in Macrophages |
| Q90131561 | Biomarkers for Detecting Resilience against Mycobacterial Disease in Animals |
| Q40425744 | CD36-Mediated Uptake of Surfactant Lipids by Human Macrophages Promotes Intracellular Growth of Mycobacterium tuberculosis |
| Q34391443 | Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases |
| Q36964224 | Changes in the major cell envelope components of Mycobacterium tuberculosis during in vitro growth |
| Q40046304 | Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals |
| Q35111159 | Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model |
| Q49294587 | Clinical relevance of LINC00152 and its variants in western Chinese tuberculosis patients |
| Q36689158 | Current understanding on micro RNAs and its regulation in response to Mycobacterial infections |
| Q98289398 | DHX36, BAX, and ARPC1B May Be Critical for the Diagnosis and Treatment of Tuberculosis |
| Q39688235 | Dectin-1 is required for miR155 upregulation in murine macrophages in response to Candida albicans. |
| Q38914054 | Dietary apigenin reduces LPS-induced expression of miR-155 restoring immune balance during inflammation |
| Q35656643 | Differential MicroRNA Expression in Human Macrophages with Mycobacterium tuberculosis Infection of Beijing/W and Non-Beijing/W Strain Types |
| Q39037574 | Differential expression of miRNAs by macrophages infected with virulent and avirulent Mycobacterium tuberculosis |
| Q34308451 | Differential expression of microRNAs in Francisella tularensis-infected human macrophages: miR-155-dependent downregulation of MyD88 inhibits the inflammatory response |
| Q36594402 | Diverse functions of miR-125 family in different cell contexts |
| Q36499296 | Down regulated lncRNA MEG3 eliminates mycobacteria in macrophages via autophagy |
| Q38785708 | Emerging role of microRNAs in regulating macrophage activation and polarization in immune response and inflammation |
| Q91000091 | Epigenetic regulation of macrophages: from homeostasis maintenance to host defense |
| Q38163413 | Epigenetics in immune-mediated pulmonary diseases |
| Q38639010 | Epigenetics and miRNA during bacteria-induced host immune responses |
| Q30407671 | Estrogen modulation of endosome-associated toll-like receptor 8: an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus. |
| Q37736350 | Extracellular vesicle-mediated export of fungal RNA. |
| Q37345281 | Genetic-and-Epigenetic Interspecies Networks for Cross-Talk Mechanisms in Human Macrophages and Dendritic Cells during MTB Infection. |
| Q38637067 | Guanine nucleotide exchange factor -H1 promotes inflammatory cytokine production and intracellular mycobacterial elimination in macrophages. |
| Q42103611 | High serum miR-183 level is associated with the bioactivity of macrophage derived from tuberculosis patients |
| Q35800373 | Host Transcriptional Profiles and Immunopathologic Response following Mycobacterium avium subsp. paratuberculosis Infection in Mice |
| Q38489473 | Host-Directed Therapies for Tuberculosis. |
| Q38196883 | Host-directed therapy of tuberculosis: what is in it for microRNA? |
| Q38776136 | Immunomodulating microRNAs of mycobacterial infections. |
| Q28390469 | Influence of Aspergillus fumigatus conidia viability on murine pulmonary microRNA and mRNA expression following subchronic inhalation exposure |
| Q36847141 | Inhibition of IFN-γ-Induced Nitric Oxide Dependent Antimycobacterial Activity by miR-155 and C/EBPβ |
| Q36755634 | Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition |
| Q27000486 | Innate immune gene polymorphisms in tuberculosis |
| Q37376368 | Involvement of eukaryotic small RNA pathways in host defense and viral pathogenesis |
| Q36056056 | Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells |
| Q38639627 | Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations |
| Q35993498 | Lung Mucosa Lining Fluid Modification of Mycobacterium tuberculosis to Reprogram Human Neutrophil Killing Mechanisms |
| Q34205049 | MAPK involvement in cytokine production in response to Corynebacterium pseudotuberculosis infection |
| Q35039679 | Macrophage immunoregulatory pathways in tuberculosis |
| Q37147624 | Macrophages in tuberculosis: friend or foe. |
| Q26744410 | Mammalian microRNAs and long noncoding RNAs in the host-bacterial pathogen crosstalk |
| Q37658428 | Mannan core branching of lipo(arabino)mannan is required for mycobacterial virulence in the context of innate immunity |
| Q64974000 | Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis. |
| Q37997926 | MiR-125 in normal and malignant hematopoiesis |
| Q35028282 | MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways |
| Q41904103 | MiR-155 induction by microbes/microbial ligands requires NF-κB-dependent de novo protein synthesis |
| Q40932500 | MicroRNA 17-5p regulates autophagy in Mycobacterium tuberculosis-infected macrophages by targeting Mcl-1 and STAT3. |
| Q33783769 | MicroRNA 26a (miR-26a)/KLF4 and CREB-C/EBPβ regulate innate immune signaling, the polarization of macrophages and the trafficking of Mycobacterium tuberculosis to lysosomes during infection. |
| Q52595686 | MicroRNA expression profiles of bovine monocyte-derived macrophages infected in vitro with two strains of Streptococcus agalactiae. |
| Q44447849 | MicroRNA expression profiling of PPD-B stimulated PBMC from M. bovis-challenged unvaccinated and BCG vaccinated cattle |
| Q40444262 | MicroRNA expression signatures in lungs of mice infected with Mycobacterium tuberculosis |
| Q40523308 | MicroRNA-125b Prevents Cardiac Dysfunction in Polymicrobial Sepsis by Targeting TRAF6-Mediated Nuclear Factor κB Activation and p53-Mediated Apoptotic Signaling |
| Q33648129 | MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. |
| Q36090085 | MicroRNA-125b-5p suppresses Brucella abortus intracellular survival via control of A20 expression. |
| Q36960767 | MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis |
| Q41352542 | MicroRNA-155 knockout mice are susceptible to Mycobacterium tuberculosis infection. |
| Q35018081 | MicroRNA-155 promotes autophagy to eliminate intracellular mycobacteria by targeting Rheb |
| Q37259224 | MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment |
| Q93011555 | MicroRNA-889 Inhibits Autophagy To Maintain Mycobacterial Survival in Patients with Latent Tuberculosis Infection by Targeting TWEAK |
| Q40044861 | MicroRNA: Dynamic Regulators of Macrophage Polarization and Plasticity |
| Q38116527 | MicroRNAs and bacterial infection. |
| Q36547119 | MicroRNAs in immune response and macrophage polarization. |
| Q26828842 | MicroRNAs in the interaction between host and bacterial pathogens |
| Q38095501 | MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer |
| Q34261814 | Microarray analysis of the effect of Streptococcus equi subsp. zooepidemicus M-like protein in infecting porcine pulmonary alveolar macrophage |
| Q26740514 | Modulation of Host miRNAs by Intracellular Bacterial Pathogens |
| Q38783180 | Mycobacterium bovis BCG Interferes with miR-3619-5p Control of Cathepsin S in the Process of Autophagy |
| Q47657805 | Mycobacterium tuberculosis Exploits a Molecular Off Switch of the Immune System for Intracellular Survival |
| Q49412008 | Mycobacterium tuberculosis Modulates miR-106b-5p to Control Cathepsin S Expression Resulting in Higher Pathogen Survival and Poor T-Cell Activation |
| Q33822234 | Mycobacterium tuberculosis cell wall released fragments by the action of the human lung mucosa modulate macrophages to control infection in an IL-10-dependent manner |
| Q42225424 | Mycobacterium tuberculosis controls microRNA-99b (miR-99b) expression in infected murine dendritic cells to modulate host immunity |
| Q38404637 | Mycobacterium tuberculosis effectors interfering host apoptosis signaling. |
| Q30402626 | Mycobacterium tuberculosis subverts negative regulatory pathways in human macrophages to drive immunopathology. |
| Q55421316 | NF-кB increases LPS-mediated procalcitonin production in human hepatocytes. |
| Q59804818 | Non-coding RNAs Function as Immune Regulators in Teleost Fish |
| Q30413432 | Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus |
| Q42323372 | Perturbed microRNA Expression by Mycobacterium tuberculosis Promotes Macrophage Polarization Leading to Pro-survival Foam Cell. |
| Q36495576 | Phosphorylation of mitogen-activated protein kinases contributes to interferon γ production in response to Mycobacterium tuberculosis. |
| Q40234466 | Preliminary evaluation of circulating microRNAs as potential biomarkers in paracoccidioidomycosis |
| Q34983195 | Profiling microRNA expression in bovine alveolar macrophages using RNA-seq |
| Q30361227 | Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review. |
| Q38011865 | Protection versus pathology in tuberculosis: recent insights |
| Q42228817 | Restoration of innate immune activation accelerates Th1-cell priming and protection following pulmonary mycobacterial infection |
| Q58719813 | Rv2346c enhances mycobacterial survival within macrophages by inhibiting TNF-α and IL-6 production via the p38/miRNA/NF-κB pathway |
| Q39171375 | Shared characteristics between Mycobacterium tuberculosis and fungi contribute to virulence |
| Q28074775 | Small Non-Coding RNAs: New Insights in Modulation of Host Immune Response by Intracellular Bacterial Pathogens |
| Q37587009 | Small RNA-mediated regulation of host-pathogen interactions |
| Q64936338 | Taenia crassiceps-Excreted/Secreted Products Induce a Defined MicroRNA Profile that Modulates Inflammatory Properties of Macrophages. |
| Q37155730 | Targeting CBLB as a potential therapeutic approach for disseminated candidiasis |
| Q38288089 | The Role of microRNAs in Bovine Infection and Immunity |
| Q36616162 | The Transcriptional Foundations of Sp110-mediated Macrophage (RAW264.7) Resistance to Mycobacterium tuberculosis H37Ra |
| Q92712443 | The matrix vesicle cargo miR-125b accumulates in the bone matrix, inhibiting bone resorption in mice |
| Q37220779 | The regulation roles of miR-125b, miR-221 and miR-27b in porcine Salmonella infection signalling pathway |
| Q38795488 | The role of epigenetics in tuberculosis infection |
| Q34985202 | The roles of microRNAs on tuberculosis infection: meaning or myth? |
| Q38926320 | The therapeutic potential of epigenetic manipulation during infectious diseases. |
| Q54343195 | Tongxinluo inhibits vascular inflammation and neointimal hyperplasia through blockade of the positive feedback loop between miR-155 and TNF-α. |
| Q52629914 | Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. |
| Q39303790 | Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients |
| Q35202669 | bacterial infection drives the expression dynamics of microRNAs and their isomiRs |
| Q37368700 | miR-125a-5p regulates differential activation of macrophages and inflammation. |
| Q55475382 | miR-181a-5p Regulates TNF-α and miR-21a-5p Influences Gualynate-Binding Protein 5 and IL-10 Expression in Macrophages Affecting Host Control of Brucella abortus Infection. |
| Q52590768 | miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy. |
| Q38235400 | microRNAs in mycobacterial disease: friend or foe? |
| Q35979023 | γ-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206). |